No Picture
News

Arcturus Therapeutics to Report Third Quarter 2021 Financial Results and Provide Corporate Update on November 8, 2021

SAN DIEGO–(BUSINESS WIRE)—- $ARCT #ClinicalTrial–Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a leading clinical-stage messenger RNA medicines company focused on the development of infectious disease vaccines and significant opportunities within liver and respiratory […]

No Picture
Los Angeles Biotech Trending News

Alexandria Real Estate Equities, Inc., at the Vanguard of the Life Science Industry, Providing High-Quality Office/Laboratory Space to Meet Historic-High Demand, Reports: 3Q21 and YTD 3Q21 Net Income per Share – Diluted of $0.67 and $3.38, respectively; 3Q21 and YTD 3Q21 FFO per Share – Diluted, As Adjusted, of $1.95 and $5.80, respectively

PASADENA, Calif.: PASADENA, Calif., Oct. 25, 2021 /PRNewswire/ — Alexandria Real Estate Equities, Inc. (NYSE:ARE) announced financial and operating results for the third quarter ended September 30, 2021. Key highlights YTD Operating results 3Q21 3Q20 […]

News

Elizabeth Holmes sent to Walgreens a doctored report that made it look like Pfizer had endorsed Theranos’ technology

Theranos founder Elizabeth Holmes sent executives at Walgreen Boots Alliance Inc. a report that had been altered to make it look — falsely — like Pfizer Inc. had endorsed the startup’s blood testing technology, according […]

No Picture
News

Acadia Pharmaceuticals to Present Data on Pimavanserin in Patients with Parkinson’s Disease Dementia with Psychosis from the HARMONY trial at the 14th Clinical Trials on Alzheimer’s Disease (CTAD) Conference

SAN DIEGO–(BUSINESS WIRE)–Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that a scientific presentation on pimavanserin for the treatment of hallucinations and delusions in patients with Parkinson’s disease dementia will be shared at the 14th Clinical […]

No Picture
News

Just as first Lucentis biosimilar wins approval, Roche snags an OK for an easier route of administration

It’s been a month since the FDA cleared the first biosimilar to Roche’s blockbuster wet age-related macular degeneration (AMD) drug ranibizumab. But the pharma giant isn’t going down without a fight. Roche’s Genentech got approval […]